Liraglutide, sold as Saxenda® for weight loss and Victoza® for type 2 diabetes, is a prescription medication in the GLP-1 receptor agonist class.
Saxenda vs Semaglutide vs Tirzepatide: Best GLP-1 Weight Loss Options in Philadelphia
At W8MD’s Philadelphia Weight Loss Center, patients can receive physician-supervised guidance to determine whether Saxenda, Semaglutide, Tirzepatide, or another medical weight loss option is best for their needs.
What Is Saxenda?
Saxenda contains the active ingredient liraglutide. It is used with a reduced-calorie diet and increased physical activity for chronic weight management in eligible adults and some adolescents.
Liraglutide works by mimicking GLP-1, a natural hormone involved in appetite regulation, digestion, and blood sugar control. It may help patients lose weight by:
- Reducing hunger and cravings
- Increasing fullness after meals
- Slowing gastric emptying
- Supporting better blood sugar control
- Helping reduce overall calorie intake
Learn more about related weight loss terms:
Who May Qualify for Saxenda?
Saxenda may be considered for adults with:
- A BMI of 30 or higher, or
- A BMI of 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea.
Because every patient is different, W8MD evaluates each person’s medical history, weight loss goals, insurance coverage, current medications, and risk factors before recommending a treatment plan.
How Saxenda Is Taken
Saxenda is taken as a once-daily subcutaneous injection. The dose is usually increased gradually to help reduce gastrointestinal side effects such as nausea.
This daily dosing schedule is one of the main differences between Saxenda and newer once-weekly GLP-1 medications such as Semaglutide and Tirzepatide.
Saxenda vs Semaglutide vs Tirzepatide
Today, patients have more GLP-1 and incretin-based weight loss options than ever before. W8MD’s Philadelphia weight loss specialists can help compare the benefits, risks, cost, and expected results of each option.
| Medication | Active Ingredient | Brand Names | How Often Taken | Mechanism | Weight Loss Potential | Best For |
|---|---|---|---|---|---|---|
| Saxenda | Liraglutide | Saxenda®, Victoza® | Daily injection | GLP-1 receptor agonist | Moderate weight loss | Patients who tolerate liraglutide or prefer an established daily GLP-1 option |
| Semaglutide | Semaglutide | Wegovy®, Ozempic® | Usually weekly injection | Long-acting GLP-1 receptor agonist | Greater average weight loss than liraglutide in many studies | Patients seeking once-weekly GLP-1 treatment with strong weight loss data |
| Tirzepatide | Tirzepatide | Zepbound®, Mounjaro® | Weekly injection | Dual GIP and GLP-1 receptor agonist | Often among the strongest weight loss results in current studies | Patients needing powerful appetite and metabolic support, when medically appropriate |
How Saxenda Compares with Semaglutide
Semaglutide is generally considered a newer and more potent GLP-1 option for weight loss than liraglutide. While Saxenda requires daily injections, Semaglutide is commonly taken once weekly.
Potential advantages of Semaglutide:
- Once-weekly dosing
- Greater average weight loss in many clinical studies
- Strong appetite and craving control
- Useful for patients with insulin resistance or prediabetes when appropriate
Potential reasons Saxenda may still be considered:
- Some patients may tolerate liraglutide better
- Insurance coverage may differ
- Daily dosing may allow more gradual adjustment for certain patients
- Prior experience with liraglutide may guide treatment decisions
How Saxenda Compares with Tirzepatide
Tirzepatide is not only a GLP-1 medication; it also activates GIP receptors. This dual incretin action may provide stronger appetite regulation and metabolic effects for many patients.
Potential advantages of Tirzepatide:
- Once-weekly dosing
- Dual GIP/GLP-1 mechanism
- Often greater average weight loss than older GLP-1 options
- Strong effects on appetite, satiety, and blood sugar regulation
Potential reasons Saxenda may still be used:
- Medication availability
- Insurance formulary rules
- Individual tolerance
- Patient preference
- Clinical history and contraindications
Other GLP-1 and Medical Weight Loss Options
In addition to Saxenda, Semaglutide, and Tirzepatide, W8MD may discuss other prescription weight loss options when appropriate, including:
- Phentermine
- Phentermine-topiramate (Qsymia®)
- Bupropion-naltrexone (Contrave®)
- Orlistat (Xenical®, Alli®)
- Setmelanotide (Imcivree®)
For many patients, the best results come from combining the right medication with nutrition guidance, behavioral changes, sleep evaluation, and regular follow-up.
Common Side Effects of Saxenda
Like all medications, Saxenda may cause side effects. Common side effects may include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Headache
- Low blood sugar, especially in patients taking diabetes medications
- Injection-site reactions
Less common but serious risks may include pancreatitis, gallbladder problems, kidney problems related to dehydration, and possible thyroid C-cell tumor risk. Patients with a personal or family history of medullary thyroid carcinoma or MEN2 should discuss this carefully with their clinician.
Why W8MD Philadelphia Can Help You Choose the Best Medication
Choosing between Saxenda, Semaglutide, Tirzepatide, or another medication is not just about picking the newest drug. The best choice depends on your medical history, weight loss goals, insurance coverage, side effect profile, and metabolic health.
At W8MD Philadelphia Medical Weight Loss, patients receive:
- Physician-supervised weight loss evaluation
- Personalized medication selection
- Guidance on GLP-1 options including Saxenda, Semaglutide, and Tirzepatide
- Support for obesity, insulin resistance, and metabolic syndrome
- Sleep medicine evaluation when sleep apnea or poor sleep contributes to weight gain
- Ongoing monitoring to improve safety and results
Learn more:
- Medical Weight Loss Philadelphia
- Affordable GLP-1 Weight Loss Philadelphia
- Weight Loss Secrets from W8MD
- Causes of Weight Gain
FAQ: Saxenda and GLP-1 Weight Loss Medications
How does Saxenda work?
Saxenda works by activating GLP-1 receptors involved in appetite and blood sugar regulation. It helps increase fullness, reduce hunger, and lower calorie intake.
Is Saxenda safe?
Saxenda is FDA-approved for chronic weight management in eligible patients, but it is not right for everyone. A physician should review your medical history, current medications, and risk factors before treatment.
How much weight can I lose with Saxenda?
Weight loss varies. In general, Saxenda produces meaningful weight loss for some patients, but newer medications such as Semaglutide and Tirzepatide often show greater average weight loss in clinical studies.
Is Semaglutide better than Saxenda?
Semaglutide is often more convenient because it is usually taken weekly rather than daily and has shown stronger average weight loss in many trials. However, Saxenda may still be appropriate for selected patients depending on tolerance, coverage, and clinical factors.
Is Tirzepatide stronger than Saxenda?
Tirzepatide has shown very strong weight loss results in clinical studies and works through both GIP and GLP-1 receptors. However, whether it is the best option depends on the patient’s health profile and physician evaluation.
Can W8MD help me decide which GLP-1 is best?
Yes. W8MD’s Philadelphia weight loss center can evaluate your medical history, BMI, blood sugar status, medication tolerance, insurance coverage, and goals to help determine whether Saxenda, Semaglutide, Tirzepatide, or another treatment is most appropriate.
Schedule a Philadelphia GLP-1 Weight Loss Consultation
If you are considering Saxenda, Semaglutide, Tirzepatide, or another prescription weight loss medication, W8MD can help you make an informed choice.
W8MD Philadelphia Weight Loss Center
1718 Welsh Road, 2nd Floor
Philadelphia, PA 19115
Call 215-676-2334 to learn more or schedule an appointment.